Patents by Inventor Lisa Michelle Ebert

Lisa Michelle Ebert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS, PRODUCTS AND SYSTEMS FOR PROGNOSIS OF SUBJECTS SUFFERING FROM MULTIPLE MYELOMA
    Publication number: 20240110915
    Abstract: The present disclosure relates to methods, products and systems for the prognosis of subjects suffering from multiple myeloma. In certain embodiments, the present disclosure provides a method of prognosis for a subject suffering from multiple myeloma. The method comprises determining the level of desmoglein 2 (DSG2) in malignant plasma cells from the subject, wherein an increased level of DSG2 in the plasma cells is indicative of a poorer prognosis for the subject.
    Type: Application
    Filed: November 16, 2021
    Publication date: April 4, 2024
    Applicants: University of South Australia, Central Adelaide Local Health Inc, The University of Adelaide
    Inventors: Craig Thomas Wallington-Beddoe, Claudine Sharon Bonder, Lisa Michelle Ebert
  • Expression of FoxP3 by cancer cells
    Patent number: 8420791
    Abstract: The present invention relates to the treatment, diagnosis, and prophylaxis of cancer based on the expression of foxp3.
    Type: Grant
    Filed: November 27, 2007
    Date of Patent: April 16, 2013
    Assignee: Ludwig Institute for Cancer Research Ltd.
    Inventors: Lisa Michelle Ebert, Weisan Chen, Jonathan S. Cebon, Ian Davis
  • EXPRESSION OF FOXP3 BY CANCER CELLS
    Publication number: 20100143359
    Abstract: The present invention relates to the treatment, diagnosis, and prophylaxis of cancer based on the expression of foxp3.
    Type: Application
    Filed: November 27, 2007
    Publication date: June 10, 2010
    Applicant: Ludwig Institute for Cancer Research Ltd.
    Inventors: Lisa Michelle Ebert, Weisan Chen, Jonathan S. Cebon, Ian Davis